We are live on
!
Find out more
JPMIA
J.P. Marvel Investment Advisors Portfolio holdings
AUM
$705M
1-Year Est. Return
43.01%
This Fund
S&P 500
This Quarter
Est. Return
+13.68%
1 Year Est. Return
+43.01%
3 Year Est. Return
+140.86%
5 Year Est. Return
+213.54%
10 Year Est. Return
–
AUM
$621M
AUM Growth
+$43M
(+7.4%)
Cap. Flow
-$14.2M
Cap. Flow
% of AUM
-2.29%
Top 10 Holdings %
Top 10 Hldgs %
57.02%
Holding
70
New
1
Increased
12
Reduced
29
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$846K |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$781K |
| 3 |
Dell
DELL
|
+$763K |
| 4 |
AT&T
T
|
+$474K |
| 5 |
Cisco
CSCO
|
+$284K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$8.41M |
| 2 |
Akamai
AKAM
|
+$6.32M |
| 3 |
Solventum
SOLV
|
+$768K |
| 4 |
Intel
INTC
|
+$409K |
| 5 |
Walt Disney
DIS
|
+$315K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.57% |
| 2 | Healthcare | 21.04% |
| 3 | Financials | 16.24% |
| 4 | Industrials | 10.59% |
| 5 | Communication Services | 5.7% |
Similar funds
GHCMRT
IFM
TWM
SSCM
NG
SC
KM
AC
J.P. Marvel Investment Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, J.P. Marvel Investment Advisors held 70 positions worth $621M, up 7.4% from $578M the previous quarter. Its ten largest holdings account for 57% of the portfolio.
J.P. Marvel Investment Advisors's Q2 2025 filing shows 1 new, 12 increased, 29 reduced and 6 closed positions. Its largest new stake was Qualcomm: 5,745 shares worth $915K. The largest sale was Intra-Cellular Therapies Inc., an estimated $8.41M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
- J.P. Marvel Investment Advisors's largest Q2 2025 buy was Qualcomm: 5,745 shares worth $915K.
- J.P. Marvel Investment Advisors added most to Alnylam Pharmaceuticals in Q2 2025, an estimated $781K increase.
- J.P. Marvel Investment Advisors's biggest Q2 2025 reduction was Eli Lilly, cutting an estimated $297K.
- J.P. Marvel Investment Advisors fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $8.41M.
- J.P. Marvel Investment Advisors's ten largest holdings make up 57% of its $621M portfolio in Q2 2025.
- J.P. Marvel Investment Advisors opened 1 new position and closed 6 in Q2 2025.
- J.P. Marvel Investment Advisors's portfolio value rose 7.4% quarter-over-quarter to $621M.
Based on J.P. Marvel Investment Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.